Low‑molecular‑weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients

Wan,Bing; Fu,Hai‑Yan; Yin,Jiang‑Tao; Ren,Guo‑Qing

doi:10.3892/etm.2015.2795

Low‑molecular‑weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients

Authors:
- Bing Wan
- Hai‑Yan Fu
- Jiang‑Tao Yin
- Guo‑Qing Ren
View Affiliations

Affiliations: Department of Intensive Care Unit, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Department of Emergency Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China
Published online on: October 13, 2015 https://doi.org/10.3892/etm.2015.2795
Pages: 2331-2336

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The efficacy and safety of physiotherapeutic prophylaxis for venous thromboembolism in critically ill patients with heparin contraindication remains unclear. In the present study it was hypothesized that physiotherapy prophylaxis with intermittent pneumatic compression (IPC) would be safe and effective for patients unable to receive low‑molecular‑weight heparin (LMWH). In addition, this study investigated whether a combined therapy of IPC with LMWH would be more effective for the prophylaxis of deep vein thrombosis (DVT) in critical patients. A total of 500 patients were divided into four groups according to the prophylaxis of DVT. The IPC group consisted of 95 patients with heparin contraindication that received IPC treatment; the LMWH group consisted of 185 patients that received an LMWH injection; the LMWH + IPC group consisted of 75 patients that received IPC treatment and LMWH injection; and the control group consisted of 145 patients that received no IPC treatment or injection of LMWH. Each patient was evaluated clinically for development of DVT and the diagnosis was confirmed by Doppler study. Venous thromboembolism was a common complication among the trauma patients with severe injuries. Patients responded positively to the treatment used in the intervention groups. Patients exhibited an improved response to LMWH + ICP compared with IPC or LMWH alone, while no significant difference was detected between the IPC and LMWH groups. These results were applicable to patients that had a Wells score of ≥3; however, no significant differences in DVT incidence were observed among the patients who had a Wells score of <3. In this observational study, LMWH + ICP appeared to be more effective than either treatment alone in treating critically ill trauma patients with severe injuries that are at high risk for VTE and bleeding simultaneously.

View Figures

View References

1	Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA and Hamilton PA: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 335:701–707. 1996. View Article : Google Scholar : PubMed/NCBI
2	Kapoor A, Chew P, Silliman RA, Hylek EM, Katz JN, Cabral H and Berlowitz D: Venous thromboembolism after joint replacement in older male veterans with comorbidity. J Am Geriatr Soc. 61:590–601. 2013. View Article : Google Scholar : PubMed/NCBI
3	Shorr AF and Williams MD: Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost. 101:139–144. 2009.PubMed/NCBI
4	Welsby I and Ortel TL: Is it time for individualized thromboprophylaxis regimens in the ICU. Crit Care Med. 43:500–501. 2015. View Article : Google Scholar : PubMed/NCBI
5	Knudson MM: Venous thromboembolism prophylaxis: One size does not fit all: Comment on ‘Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery’. Arch Surg. 147:998–999. 2012. View Article : Google Scholar : PubMed/NCBI
6	Mahmoudi M and Sobieraj DM: The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery. Pharmacotherapy. 33:1333–1340. 2013. View Article : Google Scholar : PubMed/NCBI
7	Costantino G, Ceriani E, Rusconi AM, Podda GM, Montano N, Duca P, Cattaneo M and Casazza G: Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review. PLoS One. 7:e445532012. View Article : Google Scholar : PubMed/NCBI
8	Schenkeveld L, Pedersen SS, van Nierop JW, Lenzen MJ, de Jaegere PP, Serruys PW and van Domburg RT: Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. Am Heart J. 159:471–476. 2010. View Article : Google Scholar : PubMed/NCBI
9	Bergqvist D and Lindblad B: The thromboprophylactic effect of graded elastic compression stockings in combination with dextran 70. Arch Surg. 119:1329–1331. 1984. View Article : Google Scholar : PubMed/NCBI
10	Jones NA, Webb PJ, Rees RI and Kakkar VV: A physiological study of elastic compression stockings in venous disorders of the leg. Br J Surg. 67:569–572. 1980. View Article : Google Scholar : PubMed/NCBI
11	Sarmiento A and Goswami AD: Thromboembolic prophylaxis with use of aspirin, exercise and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg Am. 81:339–346. 1999.PubMed/NCBI
12	Clagett GP, Anderson FA Jr, Geerts W, Heit JA, Knudson M, Lieberman JR, Merli GJ and Wheeler HB: Prevention of venous thromboembolism. Chest. 114(5 Suppl): 531S–560S. 1998. View Article : Google Scholar : PubMed/NCBI
13	Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, et al: Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 83:416–420. 2000.PubMed/NCBI
14	Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE and Comerota AJ: American College of Chest Physicians: Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 133(6 Suppl): 454S–545S. 2008. View Article : Google Scholar : PubMed/NCBI
15	van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH and Hutten BA: Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 3:939–942. 2005. View Article : Google Scholar : PubMed/NCBI
16	Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, Clement C, Robinson KS and Lewandowski B: Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 350:1795–1798. 1997. View Article : Google Scholar : PubMed/NCBI
17	Heijboer H, Büller HR, Lensing AW, Turpie AG, Colly LP and ten Cate JW: A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med. 329:1365–1369. 1993. View Article : Google Scholar : PubMed/NCBI
18	Jaeger KA and Staub D: Ultrasonography for venous thromboembolism. Ultraschall Med. 32:237–240. 2011.(In English and German). View Article : Google Scholar : PubMed/NCBI
19	Kawaguchi T, Kumabe T, Kanamori M, Nakamura T, Saito R, Yamashita Y, Sonoda Y, Watanabe M and Tominaga T: Early detection of venous thromboembolism in patients with neuroepithelial tumor: Efficacy of screening with serum D-dimer measurements and Doppler ultrasonography. J Neurooncol. 101:495–504. 2011. View Article : Google Scholar : PubMed/NCBI
20	Chan WS, Spencer FA, Lee AY, Chunilal S, Douketis JD, Rodger M and Ginsberg JS: Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging. CMAJ. 185:E194–E200. 2013. View Article : Google Scholar : PubMed/NCBI
21	O'Leary DH, Kane RA and Chase BM: A prospective study of the efficacy of B-scan sonography in the detection of deep venous thrombosis in the lower extremities. J Clin Ultrasound. 16:1–8. 1988. View Article : Google Scholar : PubMed/NCBI
22	Chiasson TC, Manns BJ and Stelfox HT: An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med. 6:e10000982009. View Article : Google Scholar : PubMed/NCBI
23	Geerts WH: Prevention of venous thromboembolism in high-risk patients. Hematology AM Soc Hematol Educ Program. 2006:462–466. 2006. View Article : Google Scholar
24	De A, Roy P, Garg VK and Pandey NK: Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis. 21:57–61. 2010. View Article : Google Scholar : PubMed/NCBI
25	Rogers FB, Cipolle MD, Velmahos G, Rozycki G and Luchette FA: Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma. 53:142–164. 2002. View Article : Google Scholar : PubMed/NCBI
26	Zhao JM, He ML, Xiao ZM, Li TS, Wu H and Jiang H: Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. Cochrane Database Syst Rev. 12:CD0095432012.
27	Streiff MB and Lau BD: Thromboprophylaxis in nonsurgical patients. Hematology Am Soc Hematol Educ Program. 2012:631–637. 2012.PubMed/NCBI
28	Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, et al: Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide. Blood. 119:933–939. 2012. View Article : Google Scholar : PubMed/NCBI
29	Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I and Muller SD: Wound complications following rivaroxaban administration: A multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg Am. 94:1554–1558. 2012. View Article : Google Scholar : PubMed/NCBI
30	Hull RD, Liang J and Townshend G: Long-term low-molecular-weight heparin and the post-thrombotic syndrome: A systematic review. Am J Med. 124:756–765. 2011. View Article : Google Scholar : PubMed/NCBI
31	Riha GM, Van PY, Differding JA and Schreiber MA: Oregon Health & Science University Trauma Research Group: Incidence of deep vein thrombosis is increased with 30 mg twice daily dosing of enoxaparin compared with 40 mg daily. Am J Surg. 203:598–602. 2012. View Article : Google Scholar : PubMed/NCBI
32	Dennis M, Sandercock P, Reid J, Graham C and Forbes J: CLOTS Trials Collaboration: Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: Study protocol for a randomized controlled trial. Trials. 13:262012. View Article : Google Scholar : PubMed/NCBI
33	Sekine Y and Koh E: Thoracic surgery for patients with deep vein thrombosis. Kyobu Geka. 65:697–700. 2012.(In Japanese). PubMed/NCBI
34	Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, Comerota AJ Jr, Schlappy D and Rao AK: The fibrinolytic effects of intermittent pneumatic compression: Mechanism of enhanced fibrinolysis. Ann Surg. 226:306–313. 1997. View Article : Google Scholar : PubMed/NCBI
35	Carter C, Kelton J, Hirsh J, Cerskus A, Santos A and Gent M: The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood. 59:1239–1245. 1982.PubMed/NCBI
36	Greer IA and Nelson-Piercy C: Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood. 106:401–407. 2005. View Article : Google Scholar : PubMed/NCBI
37	Rota E, Bazzan M and Fantino G: Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). Thromb Haemost. 99:779–781. 2008.PubMed/NCBI